Novartis Set 'Responsible' Price For Kymriah, Express Scripts Says
Executive Summary
Drug pricing critic Steve Miller, chief medical officer with Express Scripts, praises Novartis' gene therapy pricing and promotes benefits of amortized payments tied to outcomes.